Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2019

Open Access 01-12-2019 | Magnetic Resonance Imaging | Case report

Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review

Authors: Francesco Lancellotti, Luca Sacco, Saverio Cerasari, Vittoria Bellato, Simone Cicconi, Antonio Ciardi, Edoardo Maria Muttillo, Tiziana Feola, Roberto Caronna, Piero Chirletti

Published in: World Journal of Surgical Oncology | Issue 1/2019

Login to get access

Abstract

Background

Intrapancreatic accessory spleen (IPAS) is an uncommon finding of pancreatic mass. Differential diagnosis with pancreatic tumor, especially with non-functional neuroendocrine tumor (NF-NET), may be very hard and sometimes it entails unnecessary surgery. A combination of CT scan, MRI, and nuclear medicine can confirm the diagnosis of IPAS. 68-Ga-Dotatoc PET/CT is the gold standard in NET diagnosis and it can allow to distinguish between IPAS and NET.

Case presentation

A 69-year-old man was admitted to our hospital for an incidental nodule in the tail of the pancreas with focal uptake of 68-Ga-dotatate at PET/CT. NET was suspected and open distal splenopancreatectomy was performed. Pathologic examination revealed an IPAS.

Conclusion

This is the second IPAS case in which a positive 68Ga-Dotatoc uptake led to a false diagnosis of pancreatic NET. Here is a proposal of a literature review.
Literature
1.
Bostanci EB, Oter V, Okten S, Küçük NO, Soydal C, Turhan N, et al. Intra-pancreatic accessory spleen mimicking pancreatic neuroendocrine tumor on 68-ga-dotatate PET/CT. Arch Iran Med. 2016;19:816–9.PubMed
2.
Kawamoto S, Johnson PT, Hall H, Cameron JL, Hruban RH, Fishman EK. Intrapancreatic accessory spleen: CT appearance and differential diagnosis. Abdom Imaging. 2012;37(5):812–27.PubMedCrossRef
3.
Halpert B, Gyorkey F. Lesions observed in accessory spleens of 311 patients. Am J Clin Pathol. 1959;32(2):165–8.PubMedCrossRef
4.
Bhutiani N, Egger ME, Doughtie CA, Burkardt ES, Scoggins CR, Martin RC 2nd, et al. Intrapancreatic accessory spleen (IPAS): a single-institution experience and review of the literature. Am J Surg. 2017;213(4):816–20.PubMedCrossRef
5.
Gastrointestinal Pathology Study Group of Korean Society of Pathologists, Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors ( GEP-NETs ) in Korea 2000-2009: Multicenter Study. Cancer Res Treat. 2012;44(3):157–65.CrossRef
6.
Halfdanarson TR, Rabe KG, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19(10):1727–33.PubMedPubMedCentralCrossRef
7.
Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103(2):153–71.PubMedPubMedCentralCrossRef
8.
Uchiyama S, Chijiiwa K, Hiyoshi M, Ohuchida J, Imamura N, Nagano M, et al. Intrapancreatic accessory spleen mimicking endocrine tumor of the pancreas: case report and review of the literature. J Gastrointest Surg. 2008;12(8):1471–3.PubMedCrossRef
9.
Ota T, Tei M, Yoshioka A, Mizuno M, Watanabe S, Seki M, et al. Intrapancreatic accessory spleen diagnosed by Technetium-99m heat damage red blood cell SPECT. J Nucl Med. 1997;38(3):494–5.PubMed
10.
Läuffer JM, Baer HU, Maurer CA, Wagner M, Zimmermann A, Büchler MW. Intrapancreatic accessory spleen. A rare cause of a pancreatic mass. Int J Pancreatol. 1999;25(1):65–8.PubMedCrossRef
11.
Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc. 2004;60(3):378–84.PubMedCrossRef
12.
Brasca LE, Zanello A, De Gaspari A, De Cobelli F, Zerbi A, Fazio F, et al. Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: magnetic resonance findings and possible diagnostic role of different nuclear medicine tests. Eur Radiol. 2004;14(7):1322–3.PubMedCrossRef
13.
Kim SH, Lee JM, Han JK, Lee JY, Kim KW, Cho KC, et al. Intrapancreatic accessory spleen: findings on MR imaging, CT, US and scintigraphy, and the pathologic analysis. Korean J Radiol. 2008;9(2):162–74.PubMedPubMedCentralCrossRef
14.
Schreiner AM, Mansoor A, Faigel DO, Morgan TK. Intrapancreatic accessory spleen: mimic of pancreatic endocrine tumor diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy. Diagnostic Cytopathology. 2018;36(4):262–5.CrossRef
15.
Belkhir SM, Archambaud F, Prigent A, Chaumet-Riffaud P. Intrapancreatic accessory spleen diagnosed on radionuclide imaging. Clin Nucl Med. 2009;34(9):642–4.PubMedCrossRef
16.
Arkadopoulos N, Athanasopoulos P, Stafyla V, Karakatsanis A, Koutoulidis V, Theodosopoulos T, Karvouni E, Smyrniotis V. Intrapancreatic accessory spleen issues: diagnostic and therapeutic challenges. J Pancreas. 2009;10(4):400–5.
17.
Lin J, Jing X. Fine-needle aspiration of intrapancreatic accessory spleen, mimic of pancreatic neoplasms. Arch Pathol Lab Med. 2010;134(10):1474–8.PubMed
18.
Kurmann A, Michel JM, Stauffer E, Egger B. Intrapancreatic accessory spleen misdiagnosed as a nonsecreting endocrine tumor: case report and review of the literature. Case Rep Gastroenterol. 2010;4(2):210–4.PubMedPubMedCentralCrossRef
19.
20.
Krishna SG, Heif MH, Sharma SG, Pandey T, Rego RF. Intrapancreatic accessory spleen: investigative dilemmas and role of EUS-guided FNA for diagnostic confirmation. J Pancreas. 2011;12(6):603–6.
21.
Toussaint E, Flamen P, Demetter P, Matos C, Van Gossum M, Delhaye M et al. A rare case of a pancreatic mass due to accessory spleen; when EUS-FNA is not enough. Endoscopy. 2011;43 Suppl 2 UCTN:E221-2.PubMedCrossRef
22.
Tatsas AD, Owens CL, Siddiqui MT, Hruban RH, Ali SZ. Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol. 2012;120(4):261–8.PubMedCrossRef
23.
Jang KM, Kim SH, Lee SJ, Park MJ, Lee MH, Choi D. Differentiation of an intrapancreatic accessory spleen from a small (< 3 cm) solid pancreatic tumor: value of diffusion-weighted MR imaging. Radiology. 2013;266(1):159–67.PubMedCrossRef
24.
Bastidas AB, Holloman D, Lankarani A, Nieto JM. Endoscopic ultrasound-guided needle-based probe confocal laser endomicroscopy (nCLE) of intrapancreatic ectopic spleen. ACG Case Rep J. 2016;3(3):196–8.PubMedPubMedCentralCrossRef
25.
Boraschi P, Donati F, Volpi A, Campori G. On the AJR viewbox. Intrapancreatic accessory spleen: diagnosis with RES-specific contrast-enhanced MRI. AJR Am J Roentgenol. 2005;184(5):1712–3.PubMedCrossRef
26.
Yang B, Valluru B, Guo YR, Cui C, Zhang P, Duan W. Significance of imaging findings in the diagnosis of heterotopic spleen-an intrapancreatic accessory spleen (IPAS): case report. Medicine (Baltimore). 2017;96(52):e9040.PubMedPubMedCentralCrossRef
27.
Matsumoto K, Kato H, Okada H. Epidermoid cyst in an intrapancreatic accessory spleen diagnosed by typical radiographic images and endoscopic ultrasound fine-needle aspiration findings with contrast agent. Clin Gastroenterol Hepatol. 2018;16(2):e13–4.PubMedCrossRef
28.
Uchida D, Tsutsumi K, Kato H, Okada H. An intrapancreatic accessory spleen that was difficult to diagnose due to temporal changes after splenectomy. Intern Med. 2018;57:681–5.PubMedCrossRef
29.
Val-Bernal JF, Martino M, Yllera-Contreras E, Castro-Senosiain B, Bueno-Ortiz P. Intrapancreatic accessory spleen. Report of four cases diagnosed by ultrasound-guided fine-needle aspiration biopsy. Rom J Morphol Embryol. 2018;59(2):619–24.PubMed
30.
Barber TW, Dixon A, Smith M, Yap KS, Kalff V. Ga-68 octreotate PET/CT and Tc-99m heat-denatured red blood cell SPECT/CT imaging of an intrapancreatic accessory spleen. Med Imaging Radiat Oncol. 2016;60(2):227–9.CrossRef
31.
Baugh KA, Villafane N, Farinas C, Dhingra S, Silberfein EJ, Massarweh NN, Cao HT, Fisher WE, Van Buren G. Pancreatic incidentalomas: a management algorithm for identifying ectopic spleens. J Surg Res. 2019;236:144–52.PubMedCrossRef
32.
Setoyama T, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Yokomakura N, et al. Alpha-catenin is a significant prognostic factor than E-cadherin in esophogeal squamous cell carcinoma. J Surg Oncol. 2007;95(2):148–55.PubMedCrossRef
33.
Huang Z, Liu F. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis. Tumour Biol. 2014;35(8):7459–65.PubMedCrossRef
34.
Modlin IM, Oberg K, Taylor A, Drozdov I, Bodei L, Kidd M. Neuroendocrine tumor biomarkers: current status and perspectives. Neuroendocrinology. 2014;100(4):265–77.PubMedCrossRef
35.
Balon HR, Brown TL, Goldsmith SJ, Silberstein EB, Krenning EP, Lang O, et al. The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0. J Nucl Med Technol. 2011;39(4):317–24.PubMedCrossRef
36.
Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES. The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nucl Med Mol Imaging. 2014;4(5):426–34.PubMedPubMedCentral
37.
Suriano S, Ceriani L, Gertsch P, Crippa S, Giovanella L. Accessory spleen mimicking a pancreatic neuroendocrine tumor. Tumori. 2011;97(6):39e–41e.PubMedCrossRef
38.
García Angarita F, Sanjuanbenito DA. Intrapancreatic accessory spleen: a rare cause of recurrence of immune thrombocytopenic purpura. Clin Case Rep. 2016;4(10):979–81.PubMedPubMedCentralCrossRef
39.
Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging. 2010;54(1):61–7.PubMed
40.
Kagna O, Pirmisashvili N, Tshori S, Freedman N, Israel O, Krausz Y. Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants. AJR. 2014;203:1317–23.PubMedCrossRef
41.
Sharma P, Arora S, Dhull VS, Naswa N, Kumar R, Ammini AC, Bal C. Evaluation of 68Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Abdom Imaging. 2015;40(2):299–309.PubMedCrossRef
42.
Mapelli P, Tam H, Sharma R, Aboagye E, Al-Nahhas A. Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreas: validation with morphological imaging. Nucl Med Commun. 2014;35(6):613–9.PubMedCrossRef
43.
Makino Y, Imai Y, Fukuda K, Seki Y, Kogita S, Sawai Y, et al. Sonazoid-enhanced ultrasonography for the diagnosis of an intrapancreatic accessory spleen: a case report. J Clin Ultrasound. 2011;39(6):344–7.PubMedCrossRef
44.
Li BQ, Xu XQ, Guo JC. Intrapancreatic accessory spleen: a diagnostic dilemma. HPB. 2018;20(11):1004–11.PubMedCrossRef
Metadata
Title
Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review
Authors
Francesco Lancellotti
Luca Sacco
Saverio Cerasari
Vittoria Bellato
Simone Cicconi
Antonio Ciardi
Edoardo Maria Muttillo
Tiziana Feola
Roberto Caronna
Piero Chirletti
Publication date
01-12-2019
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2019
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-019-1660-2

Other articles of this Issue 1/2019

World Journal of Surgical Oncology 1/2019 Go to the issue

Research

Shoulder girdle resection: surgical technique modification and introduction of a new classification system

Research

Automatic thyroid nodule recognition and diagnosis in ultrasound imaging with the YOLOv2 neural network

Research

Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil

Correspondence

Letter to the Editor concerning the article “Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer”

Research

Local excision followed by early radical surgery in rectal cancer: long-term outcome

Review

Impact of physical activity and diet on colorectal cancer survivors’ quality of life: a systematic review